Section Arrow
BWAY.NASDAQ
- Brainsway Ltd.
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 8.33
-0.15 (-1.77%)
Bid
7.3
Ask
9.96
High 8.48 
Low 8.33 
Volume 1.49K 
Regular Hours (Closed)
Last
 8.48
-0.25 (-2.86%)
Day High 
8.96 
Prev. Close
8.73 
1-M High
12.25 
Volume 
109.52K 
Bid
7.3
Ask
9.96
Day Low
8.45 
Open
8.73 
1-M Low
8.63 
Market Cap 
351.41M 
Currency 美元 
P/E 36.38 
%Yield -- 
10-SMA 10.13 
20-SMA 10.7 
50-SMA 11.85 
52-W High 17.4 
52-W Low 7.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.24/0.75
Enterprise Value
357.15M
Balance Sheet
Book Value Per Share
2.04
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
52.23M
Operating Revenue Per Share
0.64
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.